- Home
- CLST vs ANL Comparison
CLST vs ANL Comparison
Compare CLST & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- ANL
- Stock Information
- Founded
- CLST 1922
- ANL 2004
- Country
- CLST United States
- ANL Cayman Islands
- Employees
- CLST N/A
- ANL N/A
- Industry
- CLST
- ANL
- Sector
- CLST
- ANL
- Exchange
- CLST Nasdaq
- ANL Nasdaq
- Market Cap
- CLST 54.6M
- ANL 61.8M
- IPO Year
- CLST N/A
- ANL 2023
- Fundamental
- Price
- CLST $13.32
- ANL $1.79
- Analyst Decision
- CLST
- ANL Hold
- Analyst Count
- CLST 0
- ANL 1
- Target Price
- CLST N/A
- ANL N/A
- AVG Volume (30 Days)
- CLST 3.9K
- ANL 11.3K
- Earning Date
- CLST 10-23-2025
- ANL 10-21-2025
- Dividend Yield
- CLST N/A
- ANL N/A
- EPS Growth
- CLST N/A
- ANL N/A
- EPS
- CLST 0.58
- ANL N/A
- Revenue
- CLST $11,354,000.00
- ANL N/A
- Revenue This Year
- CLST N/A
- ANL N/A
- Revenue Next Year
- CLST N/A
- ANL N/A
- P/E Ratio
- CLST $23.06
- ANL N/A
- Revenue Growth
- CLST 164.54
- ANL N/A
- 52 Week Low
- CLST $10.67
- ANL $1.10
- 52 Week High
- CLST $14.23
- ANL $3.89
- Technical
- Relative Strength Index (RSI)
- CLST 70.69
- ANL 55.55
- Support Level
- CLST $13.00
- ANL $1.70
- Resistance Level
- CLST $13.22
- ANL $1.82
- Average True Range (ATR)
- CLST 0.06
- ANL 0.09
- MACD
- CLST 0.01
- ANL -0.00
- Stochastic Oscillator
- CLST 92.14
- ANL 60.33
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.